Skip to main content

Opioid Induced Constipation Drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016–2022: Credence Research

The latest market report published by Credence Research “Global Opioid Induced Constipation Drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the opioid induced constipation drugs market was valued at USD 1,933.2 Mn in 2015, and is expected to reach USD 2,779.24 Mn by 2022, expanding at a CAGR of 4.6% from 2016 to 2022; where North America is has the largest market share.
Market Insights
Opioids affect the gastrointestinal tract by increasing the required time for moving stool from the gastric system. Opioids also partially paralyze the digestive system thus leaving food remains in the GI tract for a longer time period. They also reduce digestive secretions and the urge to defecate. According to this report, North America is the largest OIC drugs market and is valued at USD 794.5 Mn in 2015.
North America has two of the most developed nations in the world with advanced and well organized healthcare infrastructures: U.S. and Canada. The overall drugs market is the largest in the U.S. The OIC drugs market in the North America is expected to maintain a steady growth and exhibit further potential with the commercialization of current pipeline drugs. Moreover, greater potential due to government initiatives to further improve healthcare services in the society by providing latest technical and pharmacological treatments support the domination of North America market. Growing lifestyle related diseases, increased healthcare spending mad technological advancement in pain management are the other prime factors responsible for the growth of this market.
Europe on the other hand, exhibits mixed markets for healthcare sector. The region constantly adopts the latest healthcare systems to provide the best possible healthcare assistance for patients. The healthcare spending of European countries is increasing considerably. According to W.H.O. estimations, in 2013, the EU spent USD 3,520 per person in healthcare. Constipation is very common in Europe and the region has the largest share in drug market for OIC treatment.
On the other hand, Asia Pacific is the fastest growing regional market for OIC drugs. Rapid evolution of healthcare infrastructure across the region, coupled with the rising incidence of OIC is the major responsible factors for the growth of OIC drugs in the region. China has the largest market share for the drugs manufacturers in this region as this is one of the most potential markets for pharmaceutical giants. The Drugs used for treatment of these disorders in APAC regions are the global brands and pharmaceutical companies who are ruling the constipation drug market. Some of the common drugs are AMITIZA, LINZEES and various others like Ironwood also has partnered linaclotide with Astellas Pharma Inc. for development and commercialization in Japan and certain other Asian countries and with AstraZeneca for development and commercialization in China.
ToC
Chapter 1 Preface
1.1 Report Scope and Description
1.2 Research Methodology
Chapter 2 Executive Summary
2.1 Opioid Induced Constipation (OIC) Drugs Market Industry Snapshot
Chapter 3 Global OIC Drugs Market Analysis
3.1 OIC Drugs Market Overview
3.2 Market Inclination Insights
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Increasing Use of Opioid
3.3.1.2 Elderly Population
3.3.1.3 Rising Opioids Prescription in North America and Europe
3.3.1.4 Large Range of Effective OIC Drugs Available
3.3.2 Restraints
3.3.2.1 Research on Pain and Next Generation Analgesics
3.3.2.2 Adverse Effects of OIC Drugs
3.3.2.3 Unawareness and hesitation among patients
Company Profiles
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290

Comments

Post a Comment

Popular posts from this blog

Home Healthcare Market has Positive Long-Term Growth Outlook 2017-2023: Credence Research

Credence Research has recently issued a new market assessment report titled “Home Healthcare – Growth, Future Prospects and Competitive Analysis, 2016 – 2023”. The global Home Healthcare Market study provides a comprehensive view of the ongoing and future phases of the Home Healthcare industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution. Browse the report at  http://www.credenceresearch.com/report/home-healthcare-market Based on geographic/regional distribution the global Home Healthcare Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Home Healthcare Market based on geographic classification is studied for North America, Europe, Asia-Pacific, Latin America, and...
Post a Comment
Read more

Rheumatoid Arthritis Therapeutics Market Assessment Report Now Available at Credence Research

Credence Research has recently issued a new market assessment report titled “ Rheumatoid Arthritis Therapeutics  – Growth, Future Prospects and Competitive Analysis, 2016 – 2024”. The global Rheumatoid Arthritis Therapeutics Market study provides a comprehensive view of the ongoing and future phases of the Rheumatoid Arthritis Therapeutics industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution. Browse the report at  http://www.credenceresearch.com/report/rheumatoid-arthritis-therapeutics-market Based on geographic/regional distribution the global Rheumatoid Arthritis Therapeutics Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Rheumatoid Arthritis Therapeutics Market based on geogra...
Post a Comment
Read more

Global Liquid Biopsy Market Dynamics, Forecast, Analysis and Supply Demand 2022: Credence Research

According to the latest report published by Credence Research, Inc. “ Liquid Biopsy Market   Growth, Future Prospects and Competitive Analysis, 2016-2022,” the liquid biopsy market was valued at USD 1,881.9 Mn in 2015, and is expected to reach USD 10,850.3 Mn by 2022, expanding at a CAGR of 24.7% from 2016 to 2022. Browse the full report Liquid Biopsy: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at  http://www.credenceresearch.com/report/liquid-biopsy-market Market Insights In the past, tissue samples extracted through biopsy were evaluated to detected malignancy. However, some micrographs delivered inconsistent and ambiguous results, thus demanding repeated procedure. The advent of molecular diagnostics and next generation sequencing offered pathologists with a powerful tool for efficient diagnosis. Even with such advances, cancer diagnosis still remained subject to the limitation of availability of biopsied tissue, which fu...
Post a Comment
Read more